(Q55467798)

12 July 2018

title

6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas. (English)

1 reference

12 July 2018

2

Franziska Bleichert

1 reference

12 July 2018

author name string

Renate Kessler

series ordinal

1

1 reference

12 July 2018

Jan-Peter Warnke

series ordinal

3

1 reference

12 July 2018

Klaus Eschrich

series ordinal

4

1 reference

12 July 2018

publication date

6 September 2007

1 reference

12 July 2018

Journal of Neuro-Oncology

published in

1 reference

12 July 2018

volume

86

1 reference

12 July 2018

issue

3

1 reference

12 July 2018

page(s)

257-264

1 reference

12 July 2018

https://scigraph.springernature.com/pub.10.1007/s11060-007-9471-7

exact match

0 references

cites work

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9471-7

High glycolysis in gliomas despite low hexokinase transcription and activity correlated to chromosome 10 loss

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9471-7

Characterization of a human placental fructose-6-phosphate, 2-kinase/fructose-2,6-bisphosphatase

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-007-9471-7

PIK3CA alterations in primary (de novo) and secondary glioblastomas.

21 January 2018

1 reference

12 December 2020

On the Origin of Cancer Cells

1 reference

12 December 2020

Genetic pathways to primary and secondary glioblastoma

1 reference

12 December 2020

Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.

1 reference

12 December 2020

Antiapoptotic function of RNA-binding protein HuR effected through prothymosin alpha

1 reference

12 December 2020

Identification of PRG1, a novel progestin-responsive gene with sequence homology to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase

1 reference

12 December 2020

Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy

1 reference

12 December 2020

PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells.

1 reference

12 December 2020

Malignant glioma: genetics and biology of a grave matter.

1 reference

12 December 2020

PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2,6-bisphosphate.

1 reference

12 December 2020

Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.

1 reference

12 December 2020

Ras transformation requires metabolic control by 6-phosphofructo-2-kinase

1 reference

12 December 2020

Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect

1 reference

12 December 2020

Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases

1 reference

12 December 2020

Genetic pathways to glioblastomas

1 reference

12 December 2020

Gene expression of GLUT3 and GLUT1 glucose transporters in human brain tumors.

1 reference

12 December 2020

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

1 reference

12 December 2020

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: suiting structure to need, in a family of tissue-specific enzymes.

1 reference

12 December 2020

Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors

1 reference

12 December 2020

Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/ fructose-2, 6-bisphosphatase gene (PFKFB3)

1 reference

12 December 2020

Overexpression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-4 in the human breast and colon malignant tumors.

1 reference

12 December 2020

High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers

1 reference

12 December 2020

Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma.

1 reference

12 December 2020

Analysis of fluid in cysts accompanying various primary and metastatic brain tumours: proteins, lactate and pH.

1 reference

12 December 2020

Expression of human placental-type 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase in various cells and cell lines

1 reference

12 December 2020

AU-rich elements: characterization and importance in mRNA degradation

1 reference

12 December 2020

Regulation of cyclooxygenase-2 expression by the translational silencer TIA-1.

1 reference

12 December 2020

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis

1 reference

12 December 2020

Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in human brain

1 reference

12 December 2020

Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression

1 reference

12 December 2020

An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: role in tumor cell glycolysis and the Warburg effect

1 reference

12 December 2020

6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis

1 reference

12 December 2020

HuR, a RNA stability factor, is expressed in malignant brain tumors and binds to adenine- and uridine-rich elements within the 3' untranslated regions of cytokine and angiogenic factor mRNAs

1 reference

12 December 2020

Metabolic patterns in malignant gliomas.

1 reference

12 December 2020

10.1007/S11060-007-9471-7

Identifiers

DOI

1 reference

12 July 2018

Dimensions Publication ID

1049617609

0 references

1 reference

12 July 2018